With a dwindling arsenal of effective treatments, physicians have worked together to add two more weapons in the fight against gonorrhea.
Gonorrhea, the most common STD in the U.S., has become resistant to a primary antibiotic method used to treat it. Previously, doctors had only one form of treatment for gonorrhea, the oral antibiotic cefixime and injectable antibiotic ceftriaxone. However, the antibiotics were becoming less effective as the bacteria continued to mutate, leaving physicians with no other options.
Federal researchers this week will announce the result of a trial of the new treatments at an international conference on sexually transmitted diseases in Vienna. Read more